Table 1. Patient and disease characteristics at baseline.
| Characteristic | No of Patients | % |
|---|---|---|
| Age, years | ||
| Median | 47 | |
| Range | 29–63 | |
| Menopausal Status | ||
| Premenopausal | 10 | 67% |
| Postmenopausal | 2 | 13% |
| Missing | 3 | 20% |
| Histology | ||
| Ductal | 12 | 80% |
| Lobular | 2 | 13.3% |
| Mixed (Ductal and Lobular) | 1 | 6.7% |
| ER/PR | ||
| ER+/PR+ | 8 | 53.3% |
| ER+/PR- | 1 | 6.7% |
| ER-/PR+ | 0 | 0% |
| ER-/PR- | 6 | 40% |
| Ki67 | ||
| <14 | 3 | 20% |
| ≥14 | 12 | 80% |
| Grade | ||
| I | 1 | 7% |
| II | 8 | 53% |
| III | 6 | 40% |
| cT | ||
| T1 | 3 | 20% |
| T2 | 8 | 53.3% |
| T3 | 1 | 7% |
| cN | ||
| N0 | 8 | 53.3% |
| N1 | 7 | 46.7% |
| Type of Treatment | ||
| Radiotherapy | ||
| No | - | - |
| Yes | 15 | 100% |
| Adjuvant Hormonal Therapy | ||
| No | 6 | 40% |
| Yes | 9 | 60% |
| Adjuvant Chemotherapy | ||
| No | 15 | 100% |
| Yes | - | - |